Showing results (601-610 of 715) with videos related to
Sort By:
Pageof 72
Journal of Neuro-Oncology|November 30, 2015
Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgeryChristopher S Grubb, Ashish Jani, Cheng-Chia Wu, et al.Rheumatology (Oxford, England)|November 17, 2022
Systemic lupus erythematosus phenotypes formed from machine learning with a specific focus on cognitive impairmentMichelle Barraclough, Lauren Erdman, Juan Pablo Diaz-Martinez, et al.CNS Oncology|February 3, 2018
Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastasesCheng-Hung Tai, Cheng-Chia Wu, Mark E Hwang, et al.JAMA Oncology|May 18, 2023
Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating ChemotherapyConnor J Kinslow, Ann Mercurio, Prashanth Kumar, et al.Neuro-Oncology|June 29, 2024
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomasConnor J Kinslow, Soumyajit Roy, Fabio M Iwamoto, et al.Rheumatology (Oxford, England)|December 8, 2017
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics RegisterEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2023
MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted GliomasConnor J Kinslow, Ali I Rae, Kekoa Taparra, et al.Journal of Neuro-Oncology|July 5, 2017
Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis developmentAnurag Saraf, Christopher S Grubb, Mark E Hwang, et al.Neuro-Oncology|July 17, 2020
Rapid, label-free detection of diffuse glioma recurrence using intraoperative stimulated Raman histology and deep neural networksTodd C Hollon, Balaji Pandian, Esteban Urias, et al.Plos One|October 29, 2014
Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomasAnne L Baldock, Sunyoung Ahn, Russell Rockne, et al.Pageof 72